We evaluated levels of serum neurofilament light chains (NfL), a known biomarker of neuroaxonal damage, in patients with cervical dystonia (CD) and healthy controls (HCs). CD patients had normal NfL levels supporting the hypothesis that CD may be considered as a functional network disorder rather than as a neurodegenerative disease.
Neurofilament assessment in patients with cervical dystonia / Ferrazzano, G.; Zingaropoli, M. A.; Costanzo, M.; Belvisi, D.; Dominelli, F.; Pasculli, P.; Ciardi, M. R.; Fabbrini, G.; Defazio, G.; Berardelli, A.; Conte, A.. - In: PARKINSONISM & RELATED DISORDERS. - ISSN 1353-8020. - 98:(2022), pp. 70-71. [10.1016/j.parkreldis.2022.04.013]
Neurofilament assessment in patients with cervical dystonia
Ferrazzano G.;Zingaropoli M. A.;Costanzo M.;Belvisi D.;Dominelli F.;Pasculli P.;Ciardi M. R.;Fabbrini G.;Berardelli A.;Conte A.
2022
Abstract
We evaluated levels of serum neurofilament light chains (NfL), a known biomarker of neuroaxonal damage, in patients with cervical dystonia (CD) and healthy controls (HCs). CD patients had normal NfL levels supporting the hypothesis that CD may be considered as a functional network disorder rather than as a neurodegenerative disease.| File | Dimensione | Formato | |
|---|---|---|---|
|
Ferrazzano_Neurofilament assessmen_2022.pdf
solo gestori archivio
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Tutti i diritti riservati (All rights reserved)
Dimensione
435.79 kB
Formato
Adobe PDF
|
435.79 kB | Adobe PDF | Contatta l'autore |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
